R&D Costs, Rx Prices, and the Formula for Success in Life Sciences Innovation, With Stephen Ezell
Innovation Files: Where Tech Meets Public Policy
00:00
Is the Rate of Return on a Covin Vaccine Really Important?
Inventure capital, nine out of ten deals fail. That means that the one that succeeds has to make a lot of money. A c b o study found that pharmocidical companies need to make a return of 62 point two % on their successful drugs. And other studies have found that probably three drugs in a given year earn enough financial return to repay company's investments in the rest of their portfolio.
Transcript
Play full episode
